Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2006.157 | A Multicenter, Randomized, Open Label Dose Finding Study of RO0503821 in Anemic Patients with Stage IIIB or IV Non-Small Cell Lung Cancer Receiving First Line Myelosuppressive Chemotherapy | Prof. Mok Tony |
| 2002.169 | A Phase II Study Of The Efficacy And Safety of Irinotecan in Combination With Capecitabine As First Line Chemotherapy in Asia Subjects With Inoperable Hepatocellular Carcinoma | Dr. Mok Tony |
| 2004.037 | A Randomized, Open-Label, Parallel Group, International, Multicenter, Phase 3 Study of Oral ZD 1839(Iressa) versus Intravenous Docetaxel (Taxotere) in Patients with Locally Advanced or Metastatic Recurrent Non-Small Cell Lung Cancer Who have Previously Received Platinum Based Chemotherapy | Prof. Mok Tony |
| 2006.201 | A Phase 3 Randomized Study to Evaluate Survival of Patients Treated with Talaporfin Sodium (LS11) and Interstitial Light Emitting Diodes (LED) as Compared to the Standard of Care Therapies in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) | Prof. Mok Tony |
| 2006.307 | Open Label Study of bevacizumab (AVASTIN_) in Combination with Platinum Containing Chemotherapy as First Line Treatment of Patients with Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer (SAIL-Safety of Avastin In Lung) | Prof. Mok Tony |
| 2007.196 | Overcoming Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Management of Advanced Stage Non-Small Cell Lung Cancer | Prof. Mok Tony |
| 2006.009 | International, Randomized, Open-label, Phase 3 Trial of Gemcitabine/ Cisplatin Plus PF-3512676 Versus Gemcitabine/Cisplatin Alone as First-line Treatment of Patients with Advanced Non-small Cell Lung Cancer | Prof. Mok Tony |
| 2005.298 | Assessment of Mediastinal Lymph Node by Diffusion Weighted Whole Body Imaging in Patients with Clinically Operable Non-Small Cell Lung Cancer | MOK SK Tony |
| 2006.122 | Radiosensitization of Hepatocellular Carcinoma by Anti-Epidermal Growth Factor Receptor Monoclonal Antibody | MOK SK Tony |
| 2007.398 | The Effect of Pharmacogenetics on Treatment Toxicities and Outcomes in East Asian and Caucasian Patients Undergoing Docetaxel or Gemcitabine-based Chemotherapy | MOK SK Tony |
| 2003.088 | A Phase 2/3, Multicenter, Randomized, Controlled, Open-Label Study of Intravenous T138067-Sodium versus Intravenous Doxorubicin in Subjects with Chemotherapy-Na_ve, Unresectable Hepatocellular Carcinoma | Prof. Mok SK Tony |
| 2005.415 | An Open Label, Randomized, Parallel Group, Multicentre, Phase III Study to Assess Efficacy, Safety and Tolerability of Gefitinib (IRESSA | Prof. Mok SK Tony |
| 2007.309 | Circulating Genomic Biomarker for Sensitivity and Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor | MOK SK Tony |
| 2001.287 | A Double-blind Randomized Placebo-control Clinical Trial of Chinese Herbal Medicine in Treatment of Advanced Non-Small Cell Lung Cancer | MOK SK Tony |
| 2005.172 | Prognostic Value of Epidermal Growth Factor Receptor Gene Mutations in Patients Who Received Cytotoxic Chemotherapy for Advanced Non-small Cell Lung Cancer | MOK SK Tony |
| 2005.099 | Low Molecular Weight Fragment Hepatitis B Viral DNA as Specific Marker for Hepatcellular Carcinoma | MOK SK Tony |
| 2005.171 | Radiosensitization of Hepatocellular Carcinoma by Epidermal Growth Factor Receptor Inhibition | MOK SK Tony |
| 2005.196 | An Expanded Access Program of Tarceva (Erlotinib) in Patients with Advanced Stage IIIB/IV Non-Small Cell Lung Cancer | Prof. Mok S.K. Tony |
| 2005.339 | An Open-Label, Phase II Trial of Patupilone (EPO906) as Monotherapy to Evaluate Activity of Patupilone in Patients with Advanced Unresectable and/ or Metastatic Hepatocellular Carcinoma (HCC) | Prof. Mok S.K. Tony |
| 2005.142 | Phase II Trial of PS-341 in Patients with Hepatocellular Carcinoma | Prof. Mok S.K. Tony |
| 2005.325 | External Radiotherapy for Unresectable Hepatocellular Carcinoma Under Respiratory Gating-Phase I/II Study | Prof. Mok S.K. Tony |
| 2003.191 | A Phase 2 Study of Fenretinide In Patients with Hormone Refractory Prostate Cancer | Prof. Mok S.K. Tony |
| 2006.303 | A Phase III, International, Randomised, Double-Blind, Parallel-Group, Multi-Centre Study to Assess the Efficacy of ZD6474 (ZACTIMA | Prof. Mok S.K. Tony |
| 2007.330 | A Multinational, Randomized, Double-Blind Study Comparing Aflibercept versus Placebo in Patients Treated with Second-Line Docetaxel after Failure of One Platinum Based Therapy for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) | Prof. Mok S.K. Tony |
| 2007.321 | A Multicenter, Randomized, Double-Blind, Controlled Phase 3, Efficacy and Safety Study of Sunitinib (SU011248) in Patients with Advanced/Metastatic Non-Small Cell Lung Cancer Treated with Erlotinib | Prof. Mok S.K. Tony |
| 2007.200 | An Open-Label, Randomized, Phase 2 Study of Efficacy and Tolerability of ABT-869 in Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | Prof. Mok S.K. Tony |
| 2003.190 | An Open Label, Randomized, Multicenter, Phase II Study to Determine Hemoglobin Dose Response, Safety and Pharmacokinetic Profile of Ro 50-3821 Given Subcutaneously Once Weekly or Once Every 3 Weeks to Anemic Patients with Stage IIIB or IV Non-Small Cell Lung Carcinoma Receiving Antineoplastic Therapy | Prof. Mok S.K. Tony |
| 2006.338 | A Multi-Center Phase III Randomized, Double-Blind Placebo-Controlled Study of the Cancer Vaccine Stimuvax_ (L-BLP25 or BLP25 liposome vaccine) in Non-Small Cell Lung Cancer (NSCLC) Subjects with Unresectable Stage III Disease | Prof. Mok S.K. Tony |
| 2007.230 | A Phase 2, Multicenter, Open Label, Randomized Trial of AMG 706 or Bevacizumab in Combination with Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer | Prof. Mok S.K. Tony |
| 2007.360 | A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemon_ive Patients with Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC) | Prof. Mok S.K. Tony |
| 2007.039 | Identify the Changes of Heart Rate in Response to Ice Pack Application to the Left Shoulder in Young Health Recreational Athletes | Ms. Mok Pik Sze |
| 2005.395 | Assessment of Spirituality in the Hong Kong Chinese Chronically Renal Failure Patients and Nurses: Development of an Instrument and Interventions | MOK Esther |
| 2006.400 | A 54-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) as Adjunctive Therapy to Acetycholinesterase Inhibitors on Cognition and Overall Clinical Response in APOEe4-Stratified Subjects with Mild to Moderate Alzheimer's Disease (REFLECT-3) | Prof. Mok CT. Vincent |
| 2007.298 | Chinese Wearing Off Questionnaire for Parkinson's Disease (PD) | MOK CT Vincent |
| 2002.334 | Pilot Study on the Safety and Efficacy of Rivastigmine(Exelon)in Chinese Patients with Subcortical Vascular Dementia | Prof. Mok CT Vincent |
| 2007.396 | Validation of the NINDS VCI Neuropsychological Protocols in Chinese Stroke Patients | MOK Chung Tong Vincents |
| 2007.299 | Genetic Studies of Parkinson's Disease | MOK Chung Tong Vincent |
| 2006.317 | A Phase 2, 12-Week, Double-Blind, Dose-Finding, Placebo-Controlled Study to Assess the Efficacy and Safety of A Range of SCH 420814 Doses (1mg BID, 2mg BID, 5mg BID, and Possibly 10mg BID) in Subjects with Moderate to Severe Parkinson | Dr. Mok C.T. Vincent |
| 2007.420 | A Phase 2, 36-Week, Open-Label, Uncontrolled Safety Follow-up Study Assessing SCH 420814 5 mg BID | Prof. Mok C.T. Vincent |
| 2006.418 | A Multi-Centre, Randomised, Double-Blind, Placebo- and Entacapone-controlled, Parallel Group Study of the Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson | Prof. Mok C.T. Vincent |
| 2006.150 | A Trial to Compare the Efficacy and Safety of Cilostazol with Clopidogrel in Patients with Symptomatic Intracranial Stenosis Subtitle : A Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II (TOSS-II) | Dr. Mok C.T. Vincent |
| 2007.381 | A 52-week Open-label Extension Study of the Long-term Safety and Efficacy of Rosiglitazone Extended-release (RSG XR) as Adjunctive Therapy to Acetylcholinesterase Inhibitors in Subjects with Mild-to-moderate Alzheimer | Prof. Mok C.T. Vincent |
| 2003.313 | A Randomized, Multicentre, Double-Blind, Placebo-Controlled, 18-Month Study of the Efficacy of Xaliproden in Patients with Mild-to-Moderate Dementia of the Alzheimer | Prof. Mok C.T. Vincent |
| 2002.171 | Phase IV, A 24-weeks Prospective, Multicentre, Randomised, Double-blind, Placebo-controlled Study of Dysport Injection for the Treatment of Upper Limb Spasticity in Early Stroke | Prof. Mok C.T. Vincent |
| 2008.366 | Open-Label Extension Study of 23 mg Donepezil SR in Patients with Moderate to Severe Alzheimer | Prof. Mok C.T. Vincent |
| 2004.031 | A Randomized Phase II Study to Evaluate the Effect of CKBM-T01 Vs Tamoxifen on Quality of Life (QOL) of Patients with Inoperable Hepatocellular Carcinoma (HCC) | Prof. Mok Tony |
| 2006.261 | Expressed Emotion, Carer Stress in First Episode Psychosis and Its Clinical Implication | MO Yi Man Flora |
| 2008.469 | A randomized controlled trial study for investigating the acute effect of static stretching in different positions on hamstring muscle flexibility in healthy people and athletes | MO Tin Yi Terry |
| 2003.174 | To Determine if Pulmonary Rehabilitation gives Additional Benefits to Patients on Tiotropium in a Primary Care Settin in Patients with Chronic Obstructive Pulmonary Disease (COPD) | Prof. Martin Lindsay |
| 2007.416 | Impact of Antimicrobial Stewardship Program on Broad Spectrum Antimicrobials Use in A Hong Kong Tertiary Care Hospital, Including Treatment Outcome in Patients on Broad Spectrum Agents for Extended Spectrum Beta-Lactamases (ESBL) Bacteraemia | MARASINGHE Thilani I. U. A. |
Page 264 of 289.